Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
158 hedge funds and large institutions have $870M invested in Avid Bioservices, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 51 increasing their positions, 59 reducing their positions, and 16 closing their positions.
803% more call options, than puts
Call options by funds: $3.16M | Put options by funds: $350K
92% more capital invested
Capital invested by funds: $453M → $870M (+$417M)
81% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 16
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
7% more funds holding
Funds holding: 147 → 158 (+11)
14% less repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 59
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$122M |
| 2 |
RIM
Ranger Investment Management
Dallas,
Texas
|
+$23.8M |
| 3 |
PCM
Palisade Capital Management
Fort Lee,
New Jersey
|
+$14.6M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$11.1M |
| 5 |
Nuveen
Charlotte,
North Carolina
|
+$8.19M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$13.2M |
| 2 |
SAM
Silvercrest Asset Management
New York
|
-$9.56M |
| 3 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$8.76M |
| 4 |
Millennium Management
New York
|
-$7.52M |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$7.3M |
CDMO Hedge Fund Activity: Q1 2021 in Review
158 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q1 2021, worth a combined $870M — up 92% from $453M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new CDMO positions and 16 closed out — a net gain of 13 holders — while 51 added to existing stakes and 59 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $122M. The largest seller was Wellington Management Group, cutting an estimated $13.2M.
- 158 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q1 2021, up from 147 in Q4 2020.
- Funds reported $870M of Avid Bioservices, Inc. Common Stock stock for Q1 2021, up 92% quarter-over-quarter.
- 29 funds opened new Avid Bioservices, Inc. Common Stock positions in Q1 2021 and 16 closed out, a net change of +13 holders.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q1 2021 was Fidelity Investments, an estimated $122M added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q1 2021 was Wellington Management Group, an estimated $13.2M sold.
Based on aggregated 13F filings for Q1 2021.